Skip to main content

Zembrace SymTouch News

Migraine? Reach for Prescription Meds, Not Ibuprofen

THURSDAY, Nov. 30, 2023 – Migraine sufferers would do better to talk to their doctor about a prescription drug than reaching for a bottle of ibuprofen, a new study finds. Drugs like triptans, ergots...

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

January 27, 2019 – Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration ...

Dr. Reddy’s Laboratories Ltd. Receives FDA Approval for Zembrace SymTouch (sumatriptan succinate) Injection for the Acute Treatment of Migraines

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine

Zembrace SymTouch patient information at Drugs.com